Q: What’s the biggest challenge in revenue integrity right now?
Goodman: One of the biggest challenges at the moment is simply keeping revenue integrity at the forefront while so many entities are still recovering from the public health emergency and trying to do more with less. Read More »
CMS boosted Medicare payment for COVID-19 vaccines administered in the patient’s home to $75 per dose, the agency announced June 9. Prior to June 9, Medicare paid $40 per dose for COVID-19 vaccines administered in the patient’s home.Read More »
NAHRI supports the professional accomplishments of all its members and the revenue integrity community at large. If you know a revenue integrity professional who has gone above and beyond in their role—be it a promotion, great idea, or helping hand—we want to help you give them a shout out.Read More »
Jugna J. Shah, MPH, CHRI, discusses why innovative therapies and technologies call for innovations in existing coding, billing, and reimbursement models.Read More »
Q: What impact has the COVID-19 public health emergency had on your chargemaster approval process? How did you adapt to chargemaster changes?Read More »
Ronald Hirsch, MD, FACP, CHCQM, CHRI, examines recent changes to commercial payer prior authorization requirements and how it affects revenue integrity.Read More »
